RAPT - RAPT Therapeutics Inc
58.02
0.040 0.069%
Share volume: 11,125,216
Last Updated: 03-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$57.98
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-06-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 155.818 M | 127.180 M | 108.465 M | 240.325 M | 187.570 M | 178.410 M | 165.739 M | |
| Current Assets | 148.360 M | 120.496 M | 102.598 M | 235.236 M | 183.196 M | 172.859 M | 161.045 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 96.262 M | 77.761 M | 60.005 M | 61.320 M | 119.019 M | 127.061 M | 119.414 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 45.317 M | 37.077 M | 37.900 M | 169.735 M | 60.257 M | 41.886 M | 37.930 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.239 M | 1.933 M | 1.653 M | 1.367 M | 1.158 M | 970.000 K | 765.000 K | |
| Other Assets | 5.219 M | 4.751 M | 4.214 M | 3.722 M | 3.216 M | 4.581 M | 3.929 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 155.818 M | 127.180 M | 108.465 M | 240.325 M | 187.570 M | 178.410 M | 165.739 M | |
| Total liabilities | 24.983 M | 17.960 M | 12.959 M | 50.421 M | 10.198 M | 14.002 M | 13.762 M | |
| Total current liabilities | 21.168 M | 14.801 M | 10.362 M | 48.351 M | 8.678 M | 13.043 M | 13.375 M | |
| Accounts Payable | 6.771 M | 2.716 M | 1.380 M | 1.275 M | 1.295 M | 4.189 M | 2.102 M | |
| Other liabilities | 3.815 M | 3.159 M | 2.597 M | 2.070 M | 1.520 M | 959.000 K | 387.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 3.815 M | 3.159 M | 2.597 M | 2.070 M | 1.520 M | 959.000 K | 387.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 130.835 M | 109.220 M | 95.506 M | 189.904 M | 177.372 M | 164.408 M | 151.977 M | |
| Common stock | 646.048 M | 652.133 M | 656.697 M | 804.401 M | 809.049 M | 813.747 M | 818.812 M | |
| Retained earnings | -515.203 M | -542.866 M | -561.298 M | -614.547 M | -631.712 M | -649.355 M | -666.935 M |